Tbx20 promotes cardiomyocyte proliferation and persistence of fetal characteristics in adult mouse hearts

Journal of Molecular and Cellular Cardiology

Volumn 62, Issue , 2013, Pages 203-213

  Chakraborty, Santanu ^a   Sengupta, Arunima ^b   Yutzey, Katherine E ^b  

^a PRESIDENCY UNIVERSITY   (India)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

BMP2 Smad1 5 8 signaling; Cardiomyocyte proliferation; Fetal gene expression; PI3K AKT GSK3 catenin signaling; Tbx20

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; CONTRACTILE PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; T BOX TRANSCRIPTION FACTOR; TBX20 PROTEIN; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; FETUS; FETUS CELL; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE OVEREXPRESSION; HEART MUSCLE CELL; IN VIVO STUDY; MALE; MOUSE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

BMP2/SMAD1/5/8 SIGNALING; CARDIOMYOCYTE PROLIFERATION; FETAL GENE EXPRESSION; PI3K/AKT/GSK3Β/Β-CATENIN SIGNALING; TBX20;

ANIMALS; BLOTTING, WESTERN; CELL AGING; CELL PROLIFERATION; CELLS, CULTURED; ECHOCARDIOGRAPHY; FEMALE; MICE; MICE, TRANSGENIC; MYOCARDIUM; MYOCYTES, CARDIAC; T-BOX DOMAIN PROTEINS;

MAMMALIA; MUS; RATTUS;

EID: 84879813840     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.05.018     Document Type: Article

References (46)

1. Ahuja P., Sdek P., MacLellan W.R. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev 2007, 87:521-544.
2. Goetz S.C., Conlon F.L. Cardiac progenitors and the embryonic cell cycle. Cell Cycle 2007, 6:1974-1981.
3. Pasumarthi K.B., Field L.J. Cardiomyocyte cell cycle regulation. Circ Res 2002, 90:1044-1054.
4. Mollova M., Bersell K., Walsh S., Savla J., Das L., Park S., et al. Cardiomyocyte proliferation contributes to heart growth in young humans. Proc Natl Acad Sci U S A 2013, 110:1446-1451.
5. Hsieh P.C., Segers V.F., Davis M.E., MacGillivray C., Gannon J., Molkentin J.D., et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med 2007, 13:970-974.
6. van Amerongen M.J., Engel F.B. Features of cardiomyocyte proliferation and its potential for cardiac regeneration. J Cell Mol Med 2008, 12:2233-2244.
7. Bergmann O., Bhardwaj R., Bernard S., Zdunek A., Barnabe-Heider F., Walsh S., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
8. Hosoda T., D'Amario D., Cabral-Da-Silva M.C., Zheng H., Padin-Iruegas M.E., Ogorek B., et al. Clonality of mouse and human cardiomyogenesis in vivo. Proc Natl Acad Sci U S A 2009, 106:17169-17174.
9. Senyo S.E., Steinhauser M.L., Pizzimenti C.L., Yang V.K., Cai L., Wang M., et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 2013, 493:433-436.
10. Kerkela R., Kockeritz L., Macaulay K., Zhou J., Doble B.W., Beahm C., et al. Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. J Clin Invest 2008, 118:3609-3618.
11. Evans-Anderson H.J., Alfieri C.M., Yutzey K.E. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors. Circ Res 2008, 102:686-694.
12. Heallen T., Zhang M., Wang J., Bonilla-Claudio M., Klysik E., Johnson R.L., et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 2011, 332:458-461.
13. Greulich F., Rudat C., Kispert A. Mechanisms of T-box gene function in the developing heart. Cardiovasc Res 2011, 91:212-222.
14. Kirk E.P., Sunde M., Costa M.W., Rankin S.A., Wolstein O., Castro M.L., et al. Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am J Hum Genet 2007, 81:280-291.
15. Posch M.G., Gramlich M., Sunde M., Schmitt K.R., Lee S.H., Richter S., et al. A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects. J Med Genet 2010, 47:230-235.
16. Cai C.L., Zhou W., Yang L., Bu L., Qyang Y., Zhang X., et al. T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis. Development 2005, 132:2475-2487.
17. Singh M.K., Christoffels V.M., Dias J.M., Trowe M.O., Petry M., Schuster-Gossler K., et al. Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2. Development 2005, 132:2697-2707.
18. Stennard F.A., Costa M.W., Lai D., Biben C., Furtado M.B., Solloway M.J., et al. Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation. Development 2005, 132:2451-2462.
19. Takeuchi J.K., Mileikovskaia M., Koshiba-Takeuchi K., Heidt A.B., Mori A.D., Arruda E.P., et al. Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motor neuron development. Development 2005, 132:2463-2474.
20. Chakraborty S., Yutzey K.E. Tbx20 regulation of cardiac cell proliferation and lineage specialization during embryonic and fetal development in vivo. Dev Biol 2012, 363:234-246.
21. Shen T., Aneas I., Sakabe N., Dirschinger R.J., Wang G., Smemo S., et al. Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function. J Clin Invest 2011, 121:4640-4654.
22. Parsons S.A., Millay D.P., Wilkins B.J., Bueno O.F., Tsika G.L., Neilson J.R., et al. Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy. J Biol Chem 2004, 279:26192-26200.
23. Levay A.K., Peacock J.D., Lu Y., Koch M., Hinton R.B., Kadler K.E., et al. Scleraxis is required for cell lineage differentiation and extracellular matrix remodeling during murine heart valve formation in vivo. Circ Res 2008, 103:948-956.
24. Hinton R.B., Lincoln J., Deutsch G.H., Osinska H., Manning P.B., Benson D.W., et al. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res 2006, 98:1431-1438.
25. Lincoln J., Florer J.B., Deutsch G.H., Wenstrup R.J., Yutzey K.E. ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. Dev Dyn 2006, 235:3295-3305.
26. Maillet M., Purcell N.H., Sargent M.A., York A.J., Bueno O.F., Molkentin J.D. DUSP6 (MKP3) null mice show enhanced ERK1/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility. J Biol Chem 2008, 283:31246-31255.
27. Maillet M., Lynch J., Sanna B., York A., Zheng Y., Molkentin J. Cdc42 is an antihypertrophic molecular switch in the mouse heart. J Clin Invest 2009, 119:3079-3088.
28. Sengupta A., Molkentin J.D., Paik J.H., DePinho R.A., Yutzey K.E. FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress. J Biol Chem 2011, 286:7468-7478.
29. Sengupta A., Molkentin J.D., Yutzey K.E. FoxO transcription factors promote autophagy in cardiomyocytes. J Biol Chem 2009, 284:28319-28331.
30. Nakayama H., Chen X., Baines C.P., Klevitsky R., Zhang X., Zhang H., et al. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Invest 2007, 117:2431-2444.
31. De Windt L.J., Lim H.W., Haq S., Force T., Molkentin J.D. Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways. J Biol Chem 2000, 275:13571-13579.
32. Shelton E.L., Yutzey K.E. Tbx20 regulation of endocardial cushion cell proliferation and extracellular matrix gene expression. Dev Biol 2007, 302:376-388.
33. Kaiser R.A., Bueno O.F., Lips D.J., Doevendans P.A., Jones F., Kimball T.F., et al. Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo. J Biol Chem 2004, 279:15524-15530.
34. Rota M., Hosoda T., De Angelis A., Arcarese M.L., Esposito G., Rizzi R., et al. The young mouse heart is composed of myocytes heterogeneous in age and function. Circ Res 2007, 101:387-399.
35. Siedner S., Kruger M., Schroeter M., Metzler D., Roell W., Fleischmann B.K., et al. Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart. J Physiol 2003, 548:493-505.
36. Xin M., Kim Y., Sutherland L.B., Qi X., McAnally J., Schwartz R.J., et al. Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci Signal 2011, 4:ra70.
37. Li P., Cavallero S., Gu Y., Chen T.H., Hughes J., Hassan A.B., et al. IGF signaling directs ventricular cardiomyocyte proliferation during embryonic heart development. Development 2011, 138:1795-1805.
38. Li F., Wang X., Capasso J.M., Gerdes A.M. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 1996, 28:1737-1746.
39. Westfall M.V., Samuelson L.C., Metzger J.M. Troponin I isoform expression is developmentally regulated in differentiating embryonic stem cell-derived cardiac myocytes. Dev Dyn 1996, 206:24-38.
40. Porrello E.R., Mahmoud A.I., Simpson E., Hill J.A., Richardson J.A., Olson E.N., et al. Transient regenerative potential of the neonatal mouse heart. Science 2011, 331:1078-1080.
41. Zhang W., Chen H., Wang Y., Yong W., Zhu W., Liu Y., et al. Tbx20 transcription factor is a downstream mediator for bone morphogenetic protein-10 in regulating cardiac ventricular wall development and function. J Biol Chem 2011, 286:36820-36829.
42. von Gise A., Lin Z., Schlegelmilch K., Honor L.B., Pan G.M., Buck J.N., et al. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc Natl Acad Sci U S A 2012, 109:2394-2399.
43. Alarcon C., Zaromytidou A.I., Xi Q., Gao S., Yu J., Fujisawa S., et al. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell 2009, 139:757-769.
44. Kajstura J., Urbanek K., Perl S., Hosoda T., Zheng H., Ogorek B., et al. Cardiomyogenesis in the adult human heart. Circ Res 2010, 207:305-315.
45. Woulfe K.C., Gao E., Lal H., Harris D., Fan Q., Vagnozzi R., et al. Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo. Circ Res 2010, 106:1635-1645.
46. Masaki M., Izumi M., Oshima Y., Nakaoka Y., Kuroda T., Kimura R., et al. Smad1 protects cardiomyocytes from ischemia-reperfusion injury. Circulation 2005, 111:2752-2759.